ExonHit Develops Prototype for Alzheimer's RNA-based Dx

Nov 09, 2007

NEW YORK (GenomeWeb News) - ExonHit said yesterday that it has developed a prototype for a blood-based diagnostic to identify patients suffering from Alzheimer’s disease.

The company said the test is based on hybridizing RNA isolated from blood on an Affymetrix microarray, and it can distinguish patients suffering from Alzheimer’s disease from those suffering from schizophrenia, bipolar disorders, and depression.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

DNA Tests Considered to Verify Relatedness at Border

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

First of 'Right to Try'

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

How Old Were They?

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.

This Week in Nature

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

Main menu